KIF20A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.37539979405688E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.93950000002297E-06 |
Normal-vs-Stage2 |
4.418700E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.608600E-04 |
Stage1-vs-Stage2 |
9.575600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.413800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.010000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.17640041941547E-10 |
Normal-vs-AfricanAmerican |
4.450600E-01 |
Normal-vs-Asian |
1.899430E-01 |
Caucasian-vs-AfricanAmerican |
3.518400E-01 |
Caucasian-vs-Asian |
2.909000E-01 |
AfricanAmerican-vs-Asian |
4.459600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.66860000000635E-05 |
Normal-vs-Female |
2.29690000019822E-07 |
Male-vs-Female |
1.057150E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.800200E-03 |
Normal-vs-Extreme_Weight |
2.97540000004926E-06 |
Normal-vs-Obese |
3.058300E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.821600E-01 |
Normal_Weight-vs-Obese |
4.488200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.814000E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.999550E-01 |
Normal-vs-Age(41-60Yrs) |
6.634000E-04 |
Normal-vs-Age(61-80Yrs) |
2.64220000001369E-06 |
Normal-vs-Age(81-100Yrs) |
5.308100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.968000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.518000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.340000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.714600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.283600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.436600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.641600E-01 |
Normal-vs-Grade 3 |
9.157600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.443000E-01 |
Grade 2-vs-Grade 4 |
5.641600E-01 |
Grade 3-vs-Grade 4 |
9.157600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.61919999963622E-07 |
Normal-vs-N1 |
4.478200E-03 |
N0-vs-N1 |
8.946800E-01 |
|
|